Na+ -Ca2+ exchanger in the plasma membrane is a bidirectional electrogenic ion trans porter that couples the translocation of Na+ in one direction with that of Ca2+ in the opposite direction. This system is involved in regulation of intracellular Ca2+ concentration via the forward mode (Ca2+ extrusion) or the reverse mode (Ca2+ influx). There are two types of the plasma membrane Na+ -Ca2+ exchanger in an animal, and they are called the cardiac type and rod outer segment type. In addition, there is an electroneutral Na+ -Ca2+ exchanger present in mitochondria. Recent studies by the molecular biology technique show that there are at least 8 isoforms of the cardiac type (NCX1), and there are two other exchangers in the brain (NCX2 and NCX3). Due to new techniques of molecular biology and electro physiology, much evidence is accumulating with respect to the structure, mechanism, regulation, and physiological and pathological roles of the Na+ -Ca2+ exchanger. This review summarizes recent progress in this research field that is of nharmacolorical interest.
I. Introduction
Na+-Ca 2+ antiport (exchange) was first reported in squid axons (1) and guinea pig heart (2) and then found in various tissues including the rod outer segment (ROS) (3 7) and in mitochondria (8 -10). The exchange in ROS differs fundamentally from that observed in the heart and in most other tissues (3-7). Na+-Ca 2+ exchange in the plasma membrane is electrogenic and is considered to contribute to regulation of intracellular Ca2+ concentra tion ([Ca 2+],). On the other hand, Na+-Ca 2+ exchange in the mitochondria is electroneutral and has a role in main taining a low intramitochondrial Ca2+ concentration by extruding Ca2+. In the cardiac muscle, much attention was focused on the exchange as a possible entry route for contractile Ca2+ on a beat-to-beat basis, as a mechanism for extrusion of Ca2+ from the cell and as a mediator of the inotropic effects of cardiac glycoside (11 15). Due to the physiological and pathological importance of intra cellular Ca2+, Na+-Ca 2+ exchange has been extensively studied at both physiological and biochemical levels. However, a number of problems interfered with the studies. First, there are multiple Ca2+ transport pathways in most cells. Second, the protein responsible for Na+ Ca2+ exchange is of low abundance in most tissues. Third, there was no specific inhibitor, drug or affinity ligands to label the protein and manipulate its exchange activity (16).
In the 1990s, modern molecular biology techniques have been applied to the Na+-Ca2+ exchange research, and much information has been accumulating about structure-function relationships and the presence of diverse isoforms of the Na+-Ca 2+ exchanger. The cardiac type Na+-Ca 2+ exchanger (NCX1) was first cloned from canine cardiac tissues in 1990 (17). Subsequently, NCX1 and several splicing isoforms of NCX1 have been cloned from several species and tissues (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . The ROS type Na+-Ca 2+ exchanger was also cloned from bovine rod outer segments in 1992 (30) . Furthermore, two isoforms of the Na+-Ca 2+ exchanger, designated as NCX2 and NCX3, were cloned from rat brain in 1994 (31) and 1996 (32) , respectively. The expression of NCX2 and NCX3 seems to be restricted to the brain and skeletal muscle. The nonmammalian Na+-Ca 2+ exchanger isoforms have also been cloned (33, 34) . The mitochondrial Na+-Ca 2+ exchanger still remains to be cloned. These studies cer tainly contribute to the advanced research on the regula tion and roles of the Na+-Ca 2+ exchanger in mammalian cells. In addition, an antisense strategy has now been ap plied to this field (35) (36) (37) (38) (39) (40) . In this review, we will attempt to review recent progress of the Na+-Ca 2+ exchanger research, especially the physiological and pathological roles of the Na+-Ca 2+ exchanger, including our studies on the exchanger in astrocytes. A more comprehensive background on this topic has been given in recent books (41, 42) . 
II. Structure
A group of the Na+-Ca 2+ exchangers comprises products of three mammalian genes. NCX1 is expressed at a high level in cardiac tissue, although it can be detect ed in several tissues (19, 25) . NCX1 is proposed to be a (45 -47) . NCX2 has generally similar functional properties to NCXI and has 65% amino acid sequence homology to NCXI. Eight isoforms for NCXI with high homology (?90%) have been identified and are called NACA1... NACA8 (48) . The only structural diversity among the NCX1 isoforms lies in a small region toward the end of the cytoplasmic loop, as a consequence of alternative splicing (25). NCX2 and NCX3 seem to be restricted to the brain and skeletal muscle (31, 32) . NCX3 has 73% amino acid sequence homology with NCXI and 75% with NCX2. The ROS Na+-Ca 2+ exchanger contains little se quence homology to NCX1, but its architecture with 11 putative transmembrane domains and a large cytoplasmic loop is similar to NCX1.
The Na+-Ca 2+ exchanger has two internal repeats called the a and 13-repeats (32) and a region of similarity to Na+, K+-ATPase (Na+, K+ pump region) (17). The a-1 and a-2 motifs are in putative transmembrane seg ments 2 3 and 8 9, respectively. The r3-1 and (3-2 motifs are in loop f. The Na+, K+ pump region is in putative transmembrane segments 4-5. The loop f has a high affinity Ca 2+ binding site that regulates the exchange activity (called the secondary Ca 2+ regulation as described below (see IV. Regulation)) (49, 50) . Mutation experiments on NCXI demonstrate that the a-repeat regions, Nat K+-pump region and some of the acidic residues may be important for the Na+-Ca 2+ exchange function (50) (51) (52) . Fig. 2 . A model of the ion transport cycle of the NCXI. E, and E2 are different states of the Na+-Ca 2+ exchanger: the ion binding sites are facing the cytoplasmic side (E,) and extracellular side (E2). The exchanger can enter an inactive state (I,) whenever the binding sites facing the cytoplasmic side are loaded with three Na+ molecules.
III. Mechanism
The Na+-Ca 2+ exchanger transports Ca2+ across the membrane in exchange for Na+ ions in a bidirectional way. The cardiac Na+-Ca 2+ exchanger exchanges three Na+ ions for each Ca 2+ ion (53) , and the ROS Na+ Ca2+ exchanger exchanges four Na+ ions for each Ca2+ ion plus each K+ ion (5, 54, 55) , indicating that the ex change reactions are electrogenic (56) (57) (58) . The cardiac Na+-Ca 2+ exchanger can also catalyze the Cat+-Ca 2+ and Na+-Na+ exchanges (46, 59, 60) . The Na+-Ca 2+ ex change cycle and its partial reactions can be described as separate movements of Na+ and Ca2+ through the ex changer (consecutive or Ping-Pong mechanism) (Fig. 2) . Kinetic studies using reconstituted proteoliposomes (61, 62) and an electrophysiological technique (60, 63, 64) showed that the apparent affinity of the exchanger for one ion increased as the concentration of the trans ion decreased, indicating a characteristic property of a con secutive reaction cycle. Ion binding sites can be assumed to have a net charge of 2. The apparent ion affinities of the exchanger depend on ion concentrations on the opposite membrane side as expected for a consecutive exchange cycle. Approximately one net positive charge is moved across the membrane electrical field during the translocation of three Na+ ions, while Ca2+ translocation is largely electrically silent: voltage-dependence resides in the binding and release of extracellular Na+. The Na+ Ca2+ exchanger will enter an inactive state when three Na+ ions are bound on the cytoplasmic side. The Na+ dependent inactivation reaction (called "transporter gating") is disturbed by limited proteolysis from the cyto plasmic side, indicating that the site is the intracellular membrane surface (64, 65) . With respect to the rate limiting reaction of the Na+-Ca 2+ exchanger, it is sug gested that the voltage-sensitive Na+ efflux limits Na+ Ca2+ exchange, while the Ca2+ efflux limits Ca 2+-Ca2+ exchange at physiological pH in the cardiac sarcolemmal preparation (66).
IV. Regulation
The regulation of the Na+-Ca 2+ exchanger has been extensively studied in cardiac sarcolemmal vesicles, squid giant axons, whole-cell voltage clamped myocytes and giant excised patches of sarcolemma. There is little regulatory information on the ROS Na+-Ca 2+ exchanger.
The factors affecting the Na+-Ca2+ exchange activity and the Na+-Ca2+ exchanger mRNA expression are summa rized in Table 1 , and some of the regulation mechanisms such as Ca 2+-activation, Na+-inactivation and ATP-acti vation are also shown in Fig. 1 . A. Substrate regulation The Na+-Ca 2+ exchanger has a relatively high affinity Ca2+ transport site at the intracellular membrane surface and a low-affinity Ca2+ transport site at the extracellular surface. The Km values of the exchanger for intracellular Ca 2+ were reporeted to be about 1-40 rM. The wide variety of the Km value may reflect different regulatory states of the exchanger. For example, ATP and Na+ affect the affinity for intracellular Ca2+. In the squid axon, the Km values for Ca2+ are about 12 ,uM and 1 3 ,uM in the absence and presence of ATP, respectively (67).
The Km value in the giant excised sarcolemmal patch is variable from about 1 to 10 1M depending on the extra cellular Na+ concentration (46) . On the other hand, the Km value for extracellular Ca2+ of the Na+-Ca 2+ exchanger is in the mM range (68) (69) (70) , which is much higher than that for intracellular Ca 2+. This property contrasts with that of the ROS Na+-Ca 2+ exchanger which has similar Km values in the 1 2 pM range at both surfaces (5). The Km value for intracellular Ca2+ is sub stantially above resting [Ca 2+]i. Then, the important question arises whether the Na+-Ca 2+ exchanger has a role in Ca2+ efflux at low [Ca 2+1,. In the cardiac muscle, the Ca2+ pump is considered to be a main pathway of Ca2+ extrusion at low [Ca 2+]i. However, the Na+-Ca 2+ exchanger alone is the only Ca2+ efflux mechanism in ROS (7, 71, 72 The Na+-Ca 2+ exchanger has Km values of 20-30 mM for Na+ at the intra and extracellular surfaces, with Hill coefficients of 2-3; and its value is almost symmetric at intracellular and extracellular surfaces (46, 47) . The Na+ transport site is specific for Na+: no other monovalent cation can substitute for Na+ in the Na+-Ca 2+ exchange reaction. Thus, the Na+-Ca 2+ exchanger in the plasma membrane contrasts with the mitochondrial one (10), which transports Li+ as well as Na+.
The reverse mode of the Na+-Ca 2+ exchanger is acti vated by intracellular Ca 2+ (46, 47) . That is, the ex changer has a high-affinity Ca 2+ regulatory site at the intra cellular surface, in addition to having a transport site for Ca 21 (49, 50) . The secondary regulation by internal Ca2+ was first observed in the squid axon (73) and then demonstrated in various intact preparations, but not in isolated plasma membrane vesicles (74) . The Kd value for Ca2+ at the regulatory site varies in the different prepara tions (in dialyzed myocytes, about 50 nM; in giant excised sarcolemmal patches, about 1 1iM). The affinity is also influenced by ATP: the Kd values in the absence and presence of ATP are about 12 and 2 pM, respectively, in the squid axon. Due to the experimental difficulty, it has not been demonstrated whether the cytosolic Ca2+ regulatory site modulates the forward mode of the Na+ Ca2+ exchanger. Although the physiological importance of the Ca2+ regulatory site is not well-understood, the implication is reported in the cardiac system (13, 14). Ca2+ entry through the Ca2+ channel upon depolariza tion could increase Ca2+ binding to the exchanger regula tory site and activate Ca2+ influx through the exchanger during the early phase of the action potential, while the exchanger may be inactivated to block further Ca2+ efflux when Ca 2+ is reduced below about 100 nM. That is, the Ca 2+ regulatory site may act as a safety valve to prevent the exchanger from lowering [Ca 2+], too far. A recent ex periment in transfected CHO cells expressing the Na+ Ca2+ exchanger shows that the Na+-Ca 2+ exchanger under goes a regulatory activation during Ca2+ release from intra cellular stores (75) .
Cytosolic Na+ promotes an inactive state of the Na+ Ca2+ exchanger: binding to Na+ at the cytoplasmic mem brane surface promotes a time-dependent entry of the exchanger into an inactive state as described above (in III. Mechanism) (64, 65) . The Na+-dependent inactiva tion is reversible upon removal of Na+ and is specific for the Na+-bound configuration. Furthermore, the inactivation is exacerbated at acidic cytosolic pH (76) and can be attenuated by increasing intracellular Ca2+ and by ATP (77) .
B. ATP and phosphorylation ATP stimulates Na+-Ca 2+ exchange activity with an increase in the affinity of the exchanger for its substrates such as Na+ and Ca 2+ in the giant axon and heart cells (46, 47, 78) . The effect of ATP in the axon requires inter nal Ca 2' and hydrolyzable ATP, suggesting the involve ment of a Ca2+-dependent protein kinase. The impor tance of the phosphorylation/dephosphorylation process in the ATP effect is supported by the experiment using vanadate in squid axon (79) . The outward Na+-Ca2+ ex change current in sarcolemmal patches is also stimulated by ATP, but the mechanism seems to contrast with that for the ATP effect observed in squid axon, since the effect is not mediated by protein kinases (74) . One hypothesis is that the effect of ATP on the Na+-Ca 2+ exchanger is due to an indirect effect on the phospholipid asymmetry of the sarcolemmal membrane (80, 81) . That is, ATP generates acidic lipids on the cytoplasmic side of the membrane in parallel with a stimulation of Na+-Ca 2+ exchange activ ity (81, 82). Hilgemann and Ball (83) have recently provided evidence that the ATP effect is mediated via phosphatidylinositol-4,5-bisphosphate (PIP2) generated from phosphatidylinositol (PI). In giant cardiac mem brane patches, the effect of ATP is abolished by a PI specific phospholipase C and is mimicked by exogenous PIP2. A positively charged cytoplasmic regulatory domain of the cardiac Na+-Ca 2+ exchanger is considered to be a PIP2 binding site (51, 84) . They (83) also showed that KATP channels, but not Na+, K+ pump and Na+ channels, had the similar sensitivity to PIP2. These ob servations indicated that it is likely that surface mem brane ion transporters and channels may be regulated by PI signaling pathways. Alternatively, ATP-dependent regulation of Na+-Ca 2+ exchange activity may be in part explained by interaction of the exchanger with the cellular cytoskeleton because treatment with cytochalasin D mim ics the effects of ATP depletion in transfected CHO cells (85). This interaction might be mediated by ankyrin, a cytoskeletal protein that has been shown to bind to the Na+-Ca 2+ exchanger (86); however, this interpretation cannot explain the effect of ATP in giant sarcolemmal patches since cytoskeletal elements appear to be absent in these patches.
There are several reports with respect to regulation by phosphorylation. Iwamoto et al. (87) demonstrated that physiological ligands such as platelet-derived growth factor and a-thrombin or phorbol esters phosphorylated serine residues of the Na+-Ca 2+ exchanger in a protein kinase C-dependent way and enhanced the exchange activity in smooth muscle cells. They (88) further showed that the Na+-Ca 2+ exchanger was up-regulated by endo thelin-1, acidic fibroblast growth factor, phorbol esters and okadaic acid, indicating the involvement of protein kinase C-catalyzed phosphorylation in the regulation. This finding implies that the Na+-Ca 2+ exchanger may play an important role in the previously reported negative inotropic actions of phorbol esters and other PKC-acti vating agents. In contrast, Smith et al. (89) reported that phorbol esters down-regulated the expression of the Na+ Ca2+ exchanger in renal epithelial cells. It is conceivable that there is a difference in the regulation mechanism of the Na+-Ca 2+ exchanger among the isoforms. Isosaki et al. (90) reported that Na+-Ca 2+ exchange activity was inhibited by the Ca 2+/calmodulin-dependent protein kinase inhibitor staurosporine in isolated bovine adrenal medullary cells. In contrast, Lin et al. (91) found that Na+-Ca 2+ exchange activity was inhibited by stimulation of protein phosphorylation in chromaffin cells. In this relation, down-regulation of the Na+-Ca 2+ exchanger by activation of adenylate cyclase was demonstrated in arterial myocytes (92) and frog ventricular myocytes (93). Fig. 3 . The Na+-Ca2+ exchanger in astrocytes. Na+-Ca2+ exchange activity, the exchanger protein and its mRNA are present in cultured astrocytes. The activity of the Na+-Ca2+ exchanger in the reverse mode is determined by Ca2+ uptake or an increase in [Ca 2+]i in the presence of ouabain and monensin. Monensin causes an increase in intracellular pH that affects Na+-Ca 2+ exchange activity, but it is likely that the monensin-induced increase in Ca 2+ uptake is due mainly to an increase in [Na+]i (unpublished).
C. Others
Many anionic lipid components and the membrane sterol component stimulate Na+-Ca 2+ exchange activity (46, 94) . The dependence of the Na+-Ca 2+ exchanger on membrane lipid environment has been shown using phospholipases, a variety of amphipathic molecules and reconstitution techniques (80, 95, 96) . The anionic lipids at the cytoplasmic surface and specific interaction be tween the Na+-Ca 2+ exchanger and cholesterol are im portant for the exchange activity (97).
It is reported that proton markedly inhibits Na+-Ca 2+ exchange activity by competing at the Ca 2+ translocation site and also possibly at the Na+ translocation site (98, 99). The sites of proton interaction are disrupted by partial proteolysis from the cytoplasmic site and thus may be located in the intracellular loop of the Na+-Ca 2+ ex changer. Relief of proton inhibition may be responsible for the stimulatory effect of proteolysis on Na+-Ca 2+ exchange activity observed in previous studies (74, 100) . In addition, the Na+-dependent component of proton inhibition may also underlie intrinsic Na+-dependent inactivation of the exchanger (76) .
K+ is obligatory for the Na+-Ca2+ exchanger in ROS, but not in other tissues as described above. Dahan et al.
(101) reported that Na+-Ca 2+ exchange activity was moderately activated by K+ in brain synaptosomes. We (70) also observed the similar K+ activation of Na+ Ca2+ exchange in cultured astrocytes.
Recent studies show that the expression of the Na+ Ca2+ exchanger mRNA is regulated by several factors such as cAMP (92), phorbol ester (89), thyroid hormone (102, 103) and glucocorticoid (104). Moreover, there are several substances affecting Na+-Ca 2+ exchange activity. Ascorbic acid decreases Na+-Ca 2+ exchange activity in brain synaptic membrane (105) and cultured astrocytes ( Fig. 3 ) (106). The effect is not related to lipid peroxida tion, although the exact mechanism for the effect is not known. The experiment in cultured astrocytes suggests that ascorbic acid acts at the intracellular sites and the inhibitory control on the exchange activity is probably indirect (106). cGMP stimulates the Na+-Ca 2+ exchange activity in smooth muscle cells (107), while it decreases the activity in cultured human mesangial cells (108). The stimulation induced by cGMP in smooth muscle cells may be involved in nitric oxide (NO)-induced vasodilation. We (109) demonstrated that NO/cGMP stimulates Na+ Ca2+ exchange activity in neuronal preparations and cul tured astrocytes (Fig. 3) . There is no evidence that the cGMP effect on the Na+-Ca 2+ exchanger is mediated by cGMP-dependent phosphorylation (107, 109). In contrast to cGMP, a cAMP analog did not affect Na+-Ca2+ ex change activity in astrocytes. Other factors such as ino sitol 1,4,5-trisphosphate (110, 111), pituitary adenylate cyclase-activating polypeptide (112), adrenomedullin (113), ovarian steroid (114), vasopressin (115) and oxida tive stress (116) are also reported to affect Na+-Ca 2+ ex change activity.
V. Physiological roles
The Na+-Ca 2+ exchanger is present in various cells and tissues, and its forward mode (Ca2+ efflux) or the reverse mode (Ca2+ influx) is involved in regulation of [Ca 2+],.
A. Cardiac muscle
It is known that a small rise in Ca 2+ concentration at the vicinity of the sarcoplasmic reticulum (SR) activates the Ca2+-release channels (ryanodine receptors) in the SR to cause a much larger release of Ca2+ ions from the SR (referred to as Ca2+-induced Ca2+ release, CICR) which then bind to troponin and activates contraction. The origin of the Ca 2+ that triggers SR Ca 2+ release has been investigated. While it is clear that L-type Ca 2+ channels (117) located in the T-tubular system can trigger SR Ca 2+ release, Ca2+ entry via the Na+-Ca 2+ exchanger is possibly involved in CICR (98, 118-120). Since the first demonstration of Ca 2+-current-independent SR Ca2+ re lease (121), evidence is accumulating that the Na+-Ca 2+ exchanger can trigger SR Ca 2+ release (13, 122, 123). However, the importance of the Na+-Ca 2+ exchanger in triggering SR Ca 2+ release under physiological conditions remains to be clarified (124). There are four Ca2+ trans port systems that compete to remove intracellular Ca2+ for ventricular relaxation. These are the SR Ca 2+ ATPase, the Na+-Ca 2+ exchanger, the sarcolemmal Ca 2+ ATPase and the mitochondrial Ca2+ uniporter. Recent studies suggest a coordinate control of the cellular Ca2+ transport processes mediated by the Na+-Ca 2+ exchanger and SR Ca 2+-ATPase (102, 125). During the normal cardiac contraction-relaxation cycle, the SR Ca 2+-ATPase and the Na+-Ca 2+ exchanger are clearly the most im portant (56, (126) (127) (128) (129) , although the relative roles vary in a species-dependent manner (130). The elementary events of SR Ca2+ release are known as Ca2+ sparks, and they take place at the T-tubular system-ryanodine receptor junction (119, 120). Thus, just as excitation-contraction coupling in the heart arises under local control of SR Ca2+ release, the Na+-Ca 2+ exchanger is well-placed to extrude the elevated [Ca 2+]; (131-136).
Iwakura et al. (137) showed that the Na+-Ca 2+ ex changer might be functionally coupled with the Na+-H+ exchanger in cardiac myocytes. al-Adrenergic stimulation enhances Na+-H+ exchange, allowing intracellular alkalinization, and that subsequent activation of Na+ Ca2+ exchange may increase Ca2+ influx. In addition, Urcelay et al. (138) suggested that a functional coupling between the plasma membrane Na+-H+ exchanger and the Na+-Ca 2+ exchanger might lead to enhanced Ca 2+ influx and stimulation of Ca2+-dependent processes dur ing al-adrenoceptor activation in liver cells. A functional coupling between the Na+-Ca 2+ exchanger and Na+,K+ ATPase was also reported in the heart: these proteins changed reciprocally in a number of models known to have altered Na+,-K+-ATPase abundance (103).
B. Smooth muscle
Several lines of evidence indicate that the Na+-Ca 2+ exchanger operates in the Ca2+ efflux mode to reduce [Ca 2+]; and cell tension in vascular smooth muscle cells. The relative contribution of the Na+-Ca 2+ exchanger, under physiological conditions, in regulation of [Ca 2+], and cell tension remains unknown. Fay and coworkers (139 141) suggested that the Na+-Ca 2+ exchanger might be involved in ~-adrenergic relaxation of smooth muscle cells. The ~-adrenergic receptor stimulation by isoproter enol activates adenylate cyclase and increases cAMP production. cAMP directly or indirectly activates the K+ channels which hyperpolarizes the cell and, in addition, stimulates the Na+ pump. The pump stimulation both hyperpolarizes the cell and decreases [Na+];, and these effects lead to operation of the forward mode (Ca2+ ex trusion) of the Na+-Ca 2+ exchanger. Contraction in response to agents, such as acetylcholine which release Ca2+ from internal stores, is therefore inhibited. Interest ingly, they (142) investigated the distribution of the Na+,K+-ATPase, the Na+-Ca 2+ exchanger, calsequestrin, a marker of the SR, and vinculin, a marker for regions of the attachment of the contractile machinery to the cell membrane, in single isolated smooth muscle cells. The Na+,K+-ATPase and the Na+-Ca 2+ exchanger are co localized in the same macrodomain on the cell membrane, which is distinct from regions occupied by vinculin, and they appear to exist close to regions occupied by calse questrin. It is likely that the Na+-Ca 2+ exchanger may have preferred access to Ca2+ from the SR, and it may be functionally coupled with Na+,K+-ATPase.
C. Brain and neurons
Neuronal Na+-Ca 2+ exchange has been investigated mainly in brain synaptosomes and synaptic plasma mem brane vesicles (143 147) and recently in cultured cells (148-150). The studies using antibodies raised against the dog heart Na+-Ca 2+ exchanger showed that cultured neurons possessed the Na+-Ca 2+ exchanger and that the Na+-Ca 2+ exchanger might be concentrated at presynap tic nerve terminals (149). Furthermore, the immuno histochemical study in a coronal section of rat hippocam pus showed that the regions containing most of the neu ronal cell bodies were only sparsely labeled with anti bodies raised against the Na+-Ca 2+ exchanger, but the synaptic regions were intensely labeled (150). In this rela tion, Kennedy and Thomas (151) reported that Na+-Ca 2+ exchange activity is not present in the cell body where [Ca 21], is regulated by the Ca2+ pump in snail neurons. With respect to the regional distribution of the Na+ Ca2+ exchanger in the brain, in situ hybridization and Northern blot studies revealed the corresponding mRNA of the Na+-Ca 2+ exchanger was present in numerous brain regions and to a lesser extent in the striatum (152). Juhaszova et al. (150, 153) have shown that the Na+ Ca2+ exchanger is much more prevalent in neurons than in astrocytes or vascular smooth muscle cells. The locali zation of the Na+-Ca 2+ exchanger implies that the Na+ Ca2+ exchanger as well as plasma membrane Ca 2+-ATPase is involved in the regulation of [Ca2+];. Although the Na+-Ca 2+ exchanger has a relatively low affinity for cytosolic Ca2+, it may influence the numerous processes that depend on the endoplasmic reticulum Ca2+ release as described in the cardiac muscle section. The Na+-Ca 2+ exchanger also may mediate net Ca2+ influx during nerve terminal depolarization. The depolarization and increase in [Na+]i as well as the transient rise in [Ca 2+], may en hance Ca2+ entry via the reverse mode of the Na+-Ca 2+ exchanger (154-156). The idea is supported by the recent observation in the synaptic membranes suggesting that the Na+-Ca 2+ exchanger is involved in Ca2+ inflow into the synaptic terminal upon stimulation (157). Gleason et al. (158, 159) also reported that the Na+-Ca 2+ ex changer may play a role in transmitter release in retinal amacrine cells. Furthermore, pharmacological evidence is accumulating that the Na+-Ca 2+ exchanger may be in volved in transmitter release (160-163). In this connec tion, evidence is reported that Na+-Ca 2+ exchange is in volved in stimulation of PI hydrolysis induced by Na+ channel opening agents and depolarization (164-167). The possible roles of the Na+-Ca 2+ exchanger in regula 
D. Astrocytes
In 1994, Goldman et al. (176) and we (70) demon strated that the Na+-Ca 2+ exchanger is present in cultured astrocytes (Fig. 3) . Several ligands such as glutamate, noradrenaline and ATP induce the Ca2+ signal in astro cytes (177). We observed that NO/cGMP stimulate Na+ Ca2+ exchange activity (109) and attenuate the Ca 2+ sig nal induced by glutamate, noradrenaline and ATP in as trocytes (39) . NO modulation of elevated [Ca 2+1, was also reported in PC12 cells, and the sites for the modulation were suggested to be voltage-sensitive Ca2+ channels (178) and phospholipase C (179). However, in experiments using antisense deoxynucleotides, we (39) demonstrated that the Na+-Ca2+ exchanger is a target of NO modula tion of the agonist-induced Ca 2+ signal in astrocytes (Fig.  4) . The studies also suggest that the Na+-Ca 2+ exchanger plays a role in the recovery of elevated [Ca 2+], to the rest ing level and imply that the exchanger may modulate the intracellular Ca2+ signaling induced by agonists in astro cytes. The idea is consistent with the recent observation in the transfected CHO cells (75) that Ca 2+ efflux via the Na+-Ca 2+ exchanger limits the rise in [Ca 2+]; during sus tained Ca2+ entry. Although the usefulness of an anti sense strategy for inhibition of exchange activity was reported in cultured myocytes (35) (36) (37) and in renal epithelial cells (40) , our result (38, 39) was the first demonstration that the antisense oligomer to the sequence encoding the NXC 1 decreased selectively the expression of the gene product. Golovina et al. (180) have recently showed that the Ca2+ content in intracellular Ca2+ stores can be regulated by the Na+-Ca 2+ exchanger in cultured mouse astrocytes.
E. Others
The kidney, like the heart and brain, is one of the richest sources of the Na+-Ca 2+ exchanger protein in an animal (19). The Na+-Ca 2+ exchanger is involved not only in transcellular Ca2+ reabsorption in the distal and connecting tubule of the nephron (181-184) but also in maintenance and regulation of [Ca 2+], in the cortical thick ascending limb of the loop of Henle (185, 186). Previous studies show that Na+-Ca 2+ exchange in renal cells is regulated by parathyroid hormone (187), vitamin D (188) and cAMP (189), and it may be modulated by phosporylation events (190, 191) .
The Na+-Ca 2+ exchanger is very widely distributed. Although this review concerns the exchangers only in the selected tissues or cells, the presence and roles of Na+ Ca2+ exchange activity are reported in other tissues or cells such as skeletal muscle (192) (193) (194) port systems such as the exchanger and Ca2+ uniporter are considered to play an important role in the overall rate of oxidative ATP synthesis. That is, an antagonist of the mitochondrial Na+-Ca 2+ exchanger would be expect ed to increase the intramitochondrial Ca2+ concentration and thereby stimulate the ATP synthesis. The pharma cological significance of the mitochondrial Na+-Ca 2+ ex changer is discussed (9, 210-213). 
VI. Pathological roles A. Cardiac muscle
The Na+-Ca 2+ exchanger has a role in the initiation of arrhythmias produced by ectopic beats generated in regions of Na+ and Ca 2+ overload (214). Each rise in internal Ca2+ activates the inward membrane current, either by activating the inward mode of the Na+-Ca 2+ exchanger or by activating nonspecific cation channels. In ventricular cells, the evidence is that the major compo nent of such oscillatory current is generated by the Na+ Ca2+ exchanger. If this inward current is sufficiently large, it may trigger ectopic beats. Expression of the cardiac Na+-Ca 2+ exchanger changes in pathological states: it decreases in global myocardial ischemia (215) and increases in animal models of cardiac hypertrophy (216) and failing human heart (217, 218). The involve ment of the Na+-Ca 2+ exchanger in pathological states such as ischemia is also shown by pharmacological and physiological experiments (118, 219-222). The increased expression and functional activity of the Na+-Ca 2+ ex changer in failing hearts may in part compensate for depressed SR Ca 2+-ATPase function, thereby limiting intracellular diastolic Ca 2+ overload (217, 223). The in crease in the Na+-Ca 2+ exchanger could also result in an increased Ca2+ influx and might be involved in the well known increased incidence of arrhythmias in patients with severe chronic heart failure (217).
B. Smooth muscle
Pharmacological studies indicate that blockade of Na+-Ca 2+ exchange activity in the vascular smooth muscle increases [Ca 2+];, resulting in vasoconstriction, increased peripheral resistance, and hypertension (224 227). Thompson et al. (228) reported that the activity of the Na+-Ca 2+ exchanger was depressed in tail arteries of stroke-prone spontaneously hypertensive rats and suggested that the change in resistance vessels would con tribute to the enhanced vascular tone present in hyper tension. Nakanishi et al. (229) showed that Na+-Ca 2+ ex change activity, unlike Na+,K+-ATPase activity, in sar colemmal vesicles from hypertrophied hearts was stimu lated compared with the control vesicles and suggested that the alteration in the Ca 2+ transport activity might serve as an adaptive mechanism during the development of cardiac hypertrophy. Furthermore, Smith and Smith (104) reported that glucocorticoids down-regulated the Na+-Ca 2+ exchanger mRNA and activity in aortic myo cytes. The effect may result in an inhibition of net Ca2+ efflux evoked by vasoconstrictors and may be involved in glucocorticoid-induced hypertension (230, 231). Blaustein and Hamlyn (224) proposed that Na+,K+-ATPase inhibi tion by endogenous circulating ouabain or a digitalis-like compound (232, 233) may cause Ca2+ entry into nerve endings and vascular smooth muscle via the Na+-Ca 2+ exchangers in both cells, resulting in vasoconstriction and hypertension.
C. Brain and neurons
Stys and co-workers (234-237), using an anoxic optic nerve model, found that anoxic injury in the central nerv ous system white matter critically depended on extracel lular Ca2+, suggesting that Ca2+ entry might be respon sible for the injury. Several lines of evidence indicate that during anoxia, Ca2+ enters the axoplasm via the reverse mode of the Na+-Ca 2+ exchanger (238-241). Anoxia produces cellular energy depletion, leading to failure of Na+,K+-ATPase.
The increase in intracellular Na+ and membrane depolarization both act to drive the Na+ Ca2+ exchanger in the reverse mode, leading to intracel lular Ca2+ overload. Interrupting the cascade at the Na+ influx process with Na+ channel blockers results in pro tection against anoxic injury (236, 237, 242, 243). The Na+-Ca 2+ exchanger blockers are also effective in pro tection against anoxic injury (236). In this relation, one hypothesis is that Na+-dependent Ca2+ extrusion is important in protecting against neuronal excitotoxicity. Mattson et al. (244) showed that removal of extracellular Na+ reduced the threshold for glutamate neurotoxicity in hippocampal neurons. On the other hand, Andreeva et al.
(148) reported that blockade of the exchange activity enhanced the development of glutamate-induced delayed neuronal death in primary cerebellar granule cell cultures. In this case, the Na+-Ca 2+ exchanger seems to operate as the forward mode (Ca2+ extrusion), and then its inhibi tion leads to enhancement of the injury.
Colvin et al. (245, 246) reported that Na+-Ca 2+ ex change activity was significantly elevated in the plasmz membranes purified from Alzheimer's disease brairr tissue. The observation seems to be consistent witll the Ca 2+ hypothesis of aging and dementia, although ar age-related change in Na+-Ca 2+ exchange activity is not confirmed (247, 248). With regard to Alzheimer's disease, Mark et al. (249) demonstrated that amyloid-~-induced neuronal death might be due to a decreased activity of Na+,K+-ATPase, but not the Na+-Ca 2+ exchanger: they could not detect any change in Na+-Ca 2+ exchange activ ity. 
D. Astrocytes
When astrocytes are exposed to Ca 2+-free medium for 10-30 min, a persistent increase in [Ca 2+], is observed immediately after reperfusion with Ca2+-containing medium, and the number of surviving cells decreased 3 5 days latter (38) . The similar cell toxicity was reported in human astrocytoma cells (250, 251) . This phenomenon is similar to Ca2+ paradox injury that is well-known in the heart (252) . Previous studies in the heart suggested that the Na+-Ca 2+ exchanger might be involved in the in jury, but conclusive evidence supporting this idea was not shown. We (38) first demonstrated using an antisense technique that the reperfusion-induced increase in
[Ca 21], is due to operation of the reverse mode of the Na+-Ca 2+ exchanger and the Ca 2+ overload results in cell toxicity (Fig. 5) . The delayed glial death is protected against by blocking Na+-Ca 2+ exchange activity with taurine, ascorbic acid and 3,4-dichlorobenzamil and is enhanced by stimulating the exchange with NO (38, 253, 254) . We also found that NO is partly involved in the toxicity (255) and that this astrocyte toxicity, like neuro nal death observed in ischemic brain, is attenuated by induction of heat shock proteins that may affect processes down stream of the increase in [Ca2+]; (256) . The Ca2+ paradox-like reaction in nervous tissue occurs in patho logical states such as ischemia (257, 258) , but it remains to be determined whether the reperfusion-induced glial cell toxicity observed in the in vitro experiment indeed occurs under the in vovo situation.
VII. Inhibitors
The previous search for inhibitors has consisted prin cipally of determining whether various inorganic cations, compounds with proven cardiovascular activities, or known blockers of other transport systems will inhibit Na+-Ca 2+ exchange. A number of compounds has been reported as inhibitors (16, 259), but none of them is specific for inhibition of Na+-Ca 2+ exchange activity. On the other hand, studies in the 1990s showed that several peptides and an isothiourea derivative are more potent inhibitors of the Na+-Ca 2+ exchanger. Structures of the typical inhibitors are shown in Fig. 6 . Fig. 6 . Inhibitors of the Na+-Ca2+ exchanger.
A. Peptides As noted above, the Na+-Ca 2+ exchanger contains a large regulatory intracellular loop (45, 118). A 20-amino acid sequence, corresponding to residues 251-270 of the NCX1, was identified on the intracellular loop as a pos sible calmodulin-binding domain with an autoinhibitory potency (XIP region in Fig. 1) (17) . The calmodulin-bind ing autoinhibitory domain of the Na+-Ca 2+ exchanger is similar to that of the plasma membrane Ca2+ pump in inhibiting the SR and plasma membrane Ca 2+ pumps (260) . The sequence is similar to that previously found in a number of calmodulin-binding proteins (261) , but there are no reports of a direct effect of calmodulin on the Na+-Ca 2+ exchanger. Li et al. (262) synthesized a family of peptides corresponding to this region and demon strated that the peptide inhibited the Na+-dependent Ca 2+ uptake in a noncompetitive manner with respect to both Na+ and Ca 2+ with an IC50 value of about 1.5 pM. This peptide (RRLLFYKYVYKRYRAGKQRG) (called XIP) has an apparent specific binding site on the intracellular surface of the exchanger (263) . XIP also inhibits Na+ Ca2+ exchange current in ventricular cells (264) and Na+ Ca2+ exchange activity in squid axon (265) . However, it is not known whether the XIP segment of the Na+-Ca 2+ exchanger interacts with this same binding site to exert a regulatory influence. Shannon et al. (84) suggested that the XIP domain may associate with the phospholipid bilayer under conditions in which Na+-Ca 2+ exchange activity is stimulated. A structural homology was sug gested among the cardiac, rat and human brain Na+ Ca2+ exchangers in the XIP binding domain (266) . XIP is more potent and specific than dichlorobenzamil (a potent amiloride derivative), but its application for physiological experiments is limited because it acts intracellularly and may interact with other calmodulin-binding proteins.
Khananshvili et al. (267) found that the tetrapeptide (FMRFa) and its analogs inhibited Na+-Ca 2+ exchange activity in the cardiac sarcolemmal vesicles with IC50 values of 10-6-10-3 M. Furthermore, they (268) tested the inhibitory potency of synthetic cyclic hexapeptides (FRCRCFa) on Na+-Ca 2+ exchange activity in view of the chemical model studies showing that the intramolecu lar cyclization of linear peptide inhibitors might restrict a conformational flexibility of the structure. FRCRCFa in hibits the Na+-dependent Ca 2+ uptake in the sarcolem mal vesicles with an IC50 value of 10 p M. FRCRCFa in hibits Na+-dependent Ca 2+ efflux (IC50 value of 2-3 pM) more potently than Na+-dependent Ca 2+ influx. This contrasts with XIP that is a more potent inhibitor of the Na+-dependent Ca2+ influx than the Na+-dependent Ca 2+ efflux (262) . These studies not only suggest that FRCRCFa and XIP may bind to distinct inhibitory sites but also imply that the forward and reverse modes of the Na+-Ca 2+ exchanger have distinct properties.
B. Chemicals
Amiloride and its derivatives have been identified as relatively effective inhibitors of the Na+-Ca 2+ exchanger (16, 259). Na+-Ca 2+ exchange activity is also inhibited by several drugs such as alcohol (269), tricyclic antidepres sants (270), calmodulin antagonists (271) and taurine (272) . The inhibitor has a positive inotropic effect (273), antiarrhythmic activity (274) and blocking effect on taurocholate-induced relaxation of guinea pig ileum smooth muscle (275) . However, their application is strict ly limited for most biomedical experiments because they inhibit a number of other Na+ transport systems and the voltage-gated Na+ and Ca 2+ channels (16, 259).
A newly synthesized compound, 2-[2-[4-(4-nitrobenzyl oxy)phenyl]ethyl]isothiourea (designated No. 7943), has recently been reported as a potent and selective inhi bitor of the Na+-Ca 2+ exchanger by Iwamoto et al. (276) and Watano et al. (277) . No. 7943 inhibits Na+-depend ent Ca2+ uptake in cardiomyocytes, smooth muscle cells and Na+-Ca 2+ exchanger-transfected fibroblasts with a IC50 of 1.2-2.4 pM, and it does not affect other transport systems at 10 pM. It may be of interest that the effect is more potent in the Ca2+ influx mode than in the Ca 2+ extrusion mode of the Na+-Ca 2+ exchanger in intact cells. This means that there is a distinct difference in properties between the forward and reverse modes of the Na+ Ca2+ exchanger, as noted in the peptide inhibitors. They (276, 277) suggested that No. 7943 could have therapeutic potential as a selective blocker of excessive Ca2+ influx mediated via the Na+-Ca 2+ exchanger under pathological conditions, which include cardiac ischemia/reperfusion, hypoxia/reoxygenation, and possibly some forms of es sential hypertension.
VIII. Conclusions
The Na+-Ca 2+ exchanger has been attractive to pharmacologists because the exchanger may be one of molecular targets for improvement of Ca 2+-mediated pathology. The most interesting point at the beginnings of Na+-Ca 2+ exchanger research was that the exchanger might be responsible for the pharmacological effect of cardiac glycosides, and its inhibitors had a positive iso tropic effect in isolated guinea pig atria (11, 12). However, there is no inhibitor of the Na+-Ca2+ ex changer that is clinically used (42) . Due to advances in the Na+-Ca 2+ exchanger research at both molecular and physiological levels in the 1990s, much is now known about the structure, mechanism, regulation, and func tional roles of the exchanger. These studies indicate that the Na+-Ca 2+ exchanger has indeed a key role of the regulation of [Ca 2+]; and may be involved in Ca2+ mediated pathological states as described above. They also raise several questions. How are the isoforms of the Na+-Ca 2+ exchanger expressed in a tissue-specific man ner? Do the isoforms have the different functions and regulation mechanisms? Are there endogenous factors affecting the Na+-Ca 2+ exchange activity, like the case of the Na+,K+-ATPase?
In the pharmacological respect, it seems worthwhile to investigate the drugs that modulate the Na+-Ca 2+ exchanger in isoform and mode-specific manners. The previous studies (262, 268, 276, 277) in dicating that the forward mode and reverse mode of the Na+-Ca 2+ exchanger have different affinity to the inhibi tors open the possibility for development of such a drug. We hope future studies will address the above questions and certainly they will contribute to the development of new drugs targeting the Na+-Ca 2+ exchanger. 
